| Rome Memorial Hospital | |
|---|---|
 | |
| Geography | |
| Location | Rome, New York, United States |
| Organization | |
| Network | St. Joseph's Health (Syracuse, New York) |
| Services | |
| Beds | 129 |
| History | |
| Opened | 1884 |
| Links | |
| Lists | Hospitals in New York State |
Rome Memorial Hospital is a medical facility in Rome, New York. They also operate an 80-bed Skilled Nursing Facility and several outpatient centers.
Rome Hospital opened in 1884 as a small cottage hospital. [1] Dr. Thomas M. Flandrau and his wife, Clarissa Foote Flandrau, are credited as establishing the hospital when it was found that there were no facilities to treat the injured after a railroad accident. Passing trains caused the small building to vibrate, and in 1887 a new hospital was built on East Garden Street. A nursing school was added in 1905. [2]
In 1920 a bequest from James A. Murphy led to the founding of a second hospital in the city, Murphy Memorial Hospital. It provided surgical services and treated patients with contagious diseases. In 1929 Murphy Memorial became a maternity hospital. [2]
In 1940 the city combined the two hospitals with a new building at its current location and called it Rome hospital & Murphy Memorial Hospital. [3] In 1976, the Bartlett Wing was added, named in honor of Dr. Robert L. Bartlett. In 1994, the city transferred ownership to a private, not-for-profit corporation, Rome Memorial Hospital. [4]
In 2017 Rome Memorial became an affiliate of St. Joseph's Health for easier access to specialty care; it retains its own separate identity. [5]
In 2018, Rome Memorial was one of seventeen upstate hospitals to take part in a pilot program to reduce the use of opioids in their emergency departments. [6]
During the COVID-19 pandemic, their primary vaccination period for the first of two shots required was from late December 2020 thru mid January 2021. [7] [8] As COVID-19 cases continued to climb, Rome Memorial expressed its gratitude for the many donations of supplies received from the community. [9]
As of 2020, Rome Memorial Hospital had 129 acute care beds, as well as accommodation for 80 residents in its skilled nursing facility; it serves about 6,000 patients a year. [4]
In 2021 Rome Memorial Hospital adopted Rome Health as its new name to more accurately reflect the scope of services provided. [10] [11]
AdventHealth is a Seventh-day Adventist non-profit health care system headquartered in Altamonte Springs, Florida, that operates facilities in 9 states across the United States. On January 2, 2019, Adventist Health System rebranded to AdventHealth. It is the largest not-for-profit Protestant health care provider in the country. In 2021, it was the second largest hospital network in Florida. On February 28, 2023, it was the fifteenth largest in the country. It operates 52 hospitals in nine states that serve more than 6.7 million patients annually.
The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert advisory committee that advises United Kingdom health departments on immunisation, making recommendations concerning vaccination schedules and vaccine safety. It has a statutory role in England and Wales, and health departments in Scotland and Northern Ireland may choose to accept its advice.
The first confirmed case of the COVID-19 pandemic in the U.S. state of Connecticut was confirmed on March 8, although there had previously been multiple people suspected of having COVID-19, all of which eventually tested negative. As of January 19, 2022, there were 599,028 confirmed cases, 68,202 suspected cases, and 9,683 COVID-associated deaths in the state.
The COVID-19 pandemic was confirmed to have reached the U.S. state of Tennessee on March 5, 2020. As of June 5, 2022, there are 2,023,815 confirmed cases, 26,103 deaths, and 12,825,885 reported tests.
CoronaVac, also known as the Sinovac COVID-19 vaccine, was a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was phase III clinically trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, another Chinese vaccine, and Covaxin, an Indian vaccine. CoronaVac does not need to be frozen, and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8 °C (36–46 °F), the temperatures at which flu vaccines are kept.
The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom.
The COVID-19 vaccination program in the Philippines was a mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.
Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden, the Public Health Agency has been commissioned by the government to create a vaccination plan. Sveriges riksbank, the central bank of Sweden, predicts that efficient vaccination against COVID-19 has macroeconomic benefits. As of 20 April 2022, 87.1% of people in Sweden have received at least one dose, with a total of 21,491,717 doses administered.: At least one vaccine has been approved for all age groups 12 and older. Children younger than 12 in high risk groups can also be vaccinated.
The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union.
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023, India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.
As of 3 January 2024, 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose. While 4.19 million vaccines were then being administered daily, only 22.3 percent of people in low-income countries had received at least a first vaccine by September 2022, according to official reports from national health agencies, which are collated by Our World in Data.
The COVID-19 vaccination programme in the Republic of Ireland is an ongoing mass immunisation campaign that began on 29 December 2020 in response to the COVID-19 pandemic in the Republic of Ireland. Ireland's vaccination rollout has been praised as one of the most successful rollouts in the world and was ranked number one in the European Union in terms of its percentage of adult population fully vaccinated, and was also ranked number one in the EU for the number of booster vaccines administered.
COVID-19 vaccination in Canada is an ongoing, intergovernmental effort coordinated between the bodies responsible in the Government of Canada to acquire and distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic in Canada. Provinces have worked with local municipal governments, hospital systems, family doctors and independently owned pharmacies to aid in part, or in full with vaccination rollout. The vaccination effort in full is the largest such immunization effort in the nation's history. The vaccination effort began December 14, 2020, and is currently ongoing.
The National COVID-19 Immunisation Programme, abbreviated as NIP or PICK, is a national vaccination campaign that is currently being implemented by the Malaysian government as an approach in curbing the spread of coronavirus disease 2019 (COVID-19) and to end the COVID-19 pandemic in Malaysia by successfully achieving the highest immunisation rate among its citizens and non-citizens that are residing in Malaysia. It is the largest immunisation programme implemented in the history of the country, and it is being administered by the Special Committee for Ensuring Access to COVID-19 Vaccine Supply (JKJAV) since early 2021.
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, and mass vaccinations began four days later. The Moderna vaccine was granted emergency use authorization on December 17, 2020, and the Janssen vaccine was granted emergency use authorization on February 27, 2021. By April 19, 2021, all U.S. states had opened vaccine eligibility to residents aged 16 and over. On May 10, 2021, the FDA approved the Pfizer-BioNTech vaccine for adolescents aged 12 to 15. On August 23, 2021, the FDA granted full approval to the Pfizer–BioNTech vaccine for individuals aged 16 and over.
COVID-19 vaccination in New Zealand began on 20 February 2021, and will continue throughout the pandemic with the goal of vaccinating all willing New Zealanders aged 5 or older. Those aged 5 to 11 require a parent, caregiver or legal guardian accompany them to their appointment and provide consent for them to be vaccinated. As of 1 September, anyone in New Zealand, regardless of their immigration status, is eligible to be vaccinated.
The COVID-19 vaccination campaign in Brazil is an ongoing mass immunization campaign for the COVID-19 pandemic in Brazil. It started on January 17, 2021, when the country had 210 thousand deaths.
The COVID-19 vaccination in Spain is the national vaccination strategy started on 27 December 2020 in order to vaccinate the country's population against COVID-19 within the international effort to fight the COVID-19 pandemic.
The COVID-19 vaccination campaign began in Fiji on the first quarter of 2021 and will continue throughout the year with the goal of vaccinating all eligible Fijians. The government has made it mandatory for all eligible adults to take the COVID-19 vaccines.
COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer-BioNTech COVID-19 vaccine were administered. In February 2021, shipments for both the Pfizer and Moderna vaccines increased significantly. By May 2021, over 50 percent of Ontarians had received their first dose. By the beginning of 2022, over 80 percent of Ontarians had received their first dose.
will begin administering the second dose of the Moderna vaccine to those who received their immunizations here, beginning Wednesday, Jan. 20.